|
J Biol Chem, Vol. 273, Issue 40, 26157-26163, October 2, 1998
A High Fat Diet Impairs Stimulation of Glucose Transport in
Muscle
FUNCTIONAL EVALUATION OF POTENTIAL MECHANISMS*
Polly A.
Hansen §,
Dong Ho
Han ¶,
Bess A.
Marshall **,
Lorraine A.
Nolte  ,
May M.
Chen ,
Mike
Mueckler§§, and
John O.
Holloszy
From the Departments of Medicine, Pediatrics,
and §§ Cell Biology and Physiology, Washington
University School of Medicine, St. Louis, Missouri 63110
 |
ABSTRACT |
A high fat diet causes resistance of
skeletal muscle glucose transport to insulin and contractions. We
tested the hypothesis that fat feeding causes a change in plasma
membrane composition that interferes with functioning of glucose
transporters and/or insulin receptors. Epitrochlearis muscles of rats
fed a high (50% of calories) fat diet for 8 weeks showed ~50%
decreases in insulin- and contraction-stimulated
3-O-methylglucose transport. Similar decreases in
stimulated glucose transport activity occurred in muscles of wild-type
mice with 4 weeks of fat feeding. In contrast, GLUT1 overexpressing
muscles of transgenic mice fed a high fat diet showed no decreases in
their high rates of glucose transport, providing evidence against
impaired glucose transporter function. Insulin-stimulated system A
amino acid transport, insulin receptor (IR) tyrosine kinase activity,
and insulin-stimulated IR and IRS-1 tyrosine phosphorylation were all
normal in muscles of rats fed the high fat diet for 8 weeks. However,
after 30 weeks on the high fat diet, there was a significant reduction
in insulin-stimulated tyrosine phosphorylation in muscle. The increases
in GLUT4 at the cell surface induced by insulin or muscle contractions,
measured with the 3H-labeled
2-N-4-(1-azi-2,2,2-trifluoroethyl)-benzoyl-1,3-bis-(D-mannose-4-yloxy)-2-propylamine photolabel, were 26-36% smaller in muscles of the 8-week high fat-fed
rats as compared with control rats. Our findings provide evidence that
(a) impairment of muscle glucose transport by 8 weeks of
high fat feeding is not due to plasma membrane composition-related reductions in glucose transporter or insulin receptor function, (b) a defect in insulin receptor signaling is a late event,
not a primary cause, of the muscle insulin resistance induced by fat feeding, and (c) impaired GLUT4 translocation to the cell
surface plays a major role in the decrease in stimulated glucose
transport.
 |
INTRODUCTION |
Rodents fed a high fat diet rapidly develop severe whole body and
skeletal muscle insulin resistance, hyperinsulinemia, hyperglycemia, and in genetically susceptible strains, diabetes (1-6). The high fat
diet-fed rodent is of interest as a research model because it might
provide insights regarding the mechanisms underlying insulin resistance
in obese individuals with impaired glucose tolerance or type 2 diabetes. For example, there is considerable experimental evidence that
insulin signaling is impaired in skeletal muscle of obese,
insulin-resistant humans (7-9), although it is still not clear if the
insulin receptor defect is a mechanism involved in the development of
the insulin resistance or is a consequence of the insulin resistance.
One purpose of this study was to determine whether an insulin-signaling
defect is involved in the development of muscle insulin resistance in
response to a high fat diet.
In addition to insulin, glucose transport in skeletal muscle can be
stimulated by muscle contractile activity or hypoxia (for review, see
Ref. 10). However, the signaling pathways by which insulin and
contractions/hypoxia stimulate glucose transport are distinct, as
evidenced by the findings that their maximal effects on glucose
transport are additive (11, 12), and the effect of insulin, but not of
contractions/hypoxia, is blocked by phosphatidylinositol 3-kinase
inhibition (13-15). In this context, the finding that stimulation of
glucose transport by muscle contractions is also impaired in high fat
diet-fed rodents (6, 16) suggests the alternative possibility that it
is a common step beyond the contraction and insulin-signaling pathways
that is involved.
Stimulation of skeletal muscle glucose transport by either insulin or
contractions is mediated by translocation of the GLUT4 isoform of the
glucose transporter to the cell surface (15, 17, 18). It has been
postulated, on the basis of findings of Zierath et al. (19),
that the insulin resistance induced by fat feeding is mediated by
decreased movement of GLUT4 transporters to the cell surface, although
this has not been a consistent finding (16). The second purpose of this
study was to re-evaluate the effect of the high fat diet on
insulin-stimulated GLUT4 translocation to the cell surface and to
determine whether the diet affects contraction-stimulated GLUT4
translocation.
The catalytic activity of the glucose transporter proteins is sensitive
to changes in the compositional and physical properties of the membrane
bilayer (20, 21), and it has been postulated that the insulin
resistance associated with high fat feeding and obesity is mediated, in
part, by membrane composition-related reductions in glucose transporter
activity (22, 23). In support of this possibility, Rosholt et
al. (16) have obtained evidence that a high fat diet results in
decreased GLUT4 intrinsic activity in skeletal muscle. The GLUT1 and
GLUT4 isoforms of the glucose transporter have a high degree of
sequence similarity (24, 25), suggesting that the basic mechanism by
which GLUT1 and GLUT4 transport glucose across the plasma membrane is
the same. If the hypothesis that a change in plasma membrane
composition interferes with GLUT4-mediated glucose transport in muscle
of fat-fed rodents is correct, it seems reasonable that glucose
transport by the GLUT1 transporter would be similarly affected. Another
purpose of the present study was to test the hypothesis that insulin
resistance in high fat diet-fed rodents is mediated by an alteration in
plasma membrane structure that interferes with glucose transporter
function. To this end, we have evaluated the effect of a high fat diet
on glucose transport in muscles of mice overexpressing the GLUT1
glucose transporter. We have also examined the effect of the high fat diet on the activity of the system A amino acid transporter, another protein whose function could be affected by compositional changes in
the plasma membrane.
 |
EXPERIMENTAL PROCEDURES |
Materials--
-[1-14C](Methylamino)isobutyrate,
D-[2-3H]-mannitol,
3-O-[3H]-methyl-D-glucose,
[14C]-mannitol, and [ -32P]ATP were all
purchased from NEN Life Science Products.
2-Deoxy-D-[1,2-3H]glucose was purchased from
American Radiolabeled Chemicals. Donkey anti-rabbit 125IgG
and reagents for ECL were obtained from Amersham Pharmacia Biotech.
Antibodies against the insulin receptor -subunit, insulin receptor
substrate-1, and phosphotyrosine were all purchased from Upstate
Biotechnology. Horseradish peroxidase-conjugated donkey anti-rabbit IgG was obtained from Jackson ImmunoResearch Laboratories. All other chemicals were obtained from Sigma. The
2-N-4-(1-azi-2,2,2-trifluoroethyl)-benzoyl-1,3-bis-(D-mannose-4-yloxy)-2-propylamine (ATB-[2-3H]BMPA)1
was kindly provided by Dr. Geoff Holman (University of Bath, United
Kingdom). Immunoprecipitation of ATB-[3H]BMPA-labeled
GLUT4 was performed using a rabbit polyclonal antibody (G4 829)
directed against the 16 carboxyl-terminal amino acids of the GLUT4
glucose transporter.
Treatment of Animals--
All experimental procedures were
approved by the Washington University Animal Studies Committee. At the
time of weaning, colony-bred male Wistar rats were assigned to either
high fat or chow diet groups. The semi-purified high fat diet was
prepared as described previously (6), with 50% of the total calories
derived from fat, 27% from sucrose, and 23% from casein. Control
animals were fed constant-formula Purina rodent chow (Purina 5001). All
diets were fed ad libitum.
Additional high fat feeding experiments were performed using mice that
overexpress the human GLUT1 glucose transporter in skeletal muscle and
their nontransgenic littermates. The construction of these mice has
been described previously (26). The minigene in this construct contains
a 2.47-kilobase cDNA fragment encoding the human GLUT1 glucose
transporter under the regulation of the 1.2-kilobase rat myosin light
chain-2 promoter. Expression of the transgene is restricted to skeletal
muscle and does not affect expression of the GLUT4 isoform. Basal
glucose transport activity in extensor digitorum longus (EDL) and
epitrochlearis muscles from GLUT1 transgenic animals is 4-8-fold
higher than in muscles from nontransgenic controls (27).
Muscle Preparation--
Rats or mice were anesthetized by an
intraperitoneal injection of pentobarbital sodium (5 mg/100 g body
weight), and the epitrochlearis and/or EDL muscles were excised. In
some experiments, muscles were stimulated to contract in
situ (see below) prior to dissection. Muscles were incubated with
shaking for 1 h at 35 °C in 2 ml of oxygenated Krebs-Henseleit
buffer (KHB) supplemented with 8 mM glucose, 32 mM mannitol, and 0.1% bovine serum albumin (BSA), with or
without a maximally effective concentration of insulin (2 milliunits/ml). Muscles were then washed in KHB containing 40 mM mannitol and 0.1% BSA, with or without insulin, for 10 min at 30 °C prior to measurement of glucose transport activity. The gas phase throughout the incubations was 95% O2, 5%
CO2.
In Situ Muscle Contractions--
Rat epitrochlearis muscles were
stimulated to contract indirectly via the nerve. Square wave pulses
(0.1 ms) were delivered with a Grass S48 stimulator at 100 Hz to give
250-ms-long trains at a rate of 60/min for 5 min. After a 1-min rest
period, the muscles were stimulated for a second 5-min interval using
the same protocol.
Measurement of Glucose Transport Activity--
Muscle glucose
transport activity was assayed using 1.0 ml of KHB containing 8 mM
3-O-[3H]methyl-D-glucose (3-MG;
2.2 µCi/ml), 32 mM [14C]mannitol (0.2 µCi/ml), 0.1% BSA, and insulin if it was present during the previous
incubation. Incubations were performed at 30 °C with a gas phase of
95% O2, 5% CO2. Extracellular space and
intracellular 3-MG concentration (µmol·ml intracellular
water 1) were determined as described previously (28). In
some experiments, glucose transport activity was measured using 1 mM 2-deoxy-D-[1,2-3H]glucose and
39 mM [14C] mannitol (27).
Measurement of System A Amino Acid Transport Activity--
The
nonmetabolizable amino acid analog -(methylamino)isobutyrate (MeAIB)
was used to measure system A amino acid transport activity as described
previously (29). Muscles were incubated in the presence or absence of 2 milliunits/ml insulin exactly as described above for the measurement of
glucose transport activity. After the wash step, muscles were incubated
at 30 °C for 20 min in 1.5 ml of KHB containing 0.1 mM
[14C]MeAIB (0.075 µCi/ml), 10 mM
D-[2-3H]mannitol (0.375 µCi/ml), 0.1% BSA,
and insulin if it was present in the previous steps.
Photolabeling of Epitrochlearis Muscles--
Cell surface GLUT4
was assessed using the ATB-[2-3H]BMPA exofacial
photolabeling technique as described previously (30), except that the
labeled GLUT4 was immunoprecipitated using a rabbit polyclonal antibody
followed by protein A-Sepharose.
Preparation of Solubilized Insulin Receptors and Receptor
Tyrosine Kinase Assay--
Insulin receptors were prepared from the
pooled gastrocnemius and plantaris muscles of one hind limb using
previously described methods (31, 32). Insulin receptors were partially
purified from solubilized muscle extracts using a wheat germ agglutinin (WGA)-Sepharose column. The ability of the solubilized insulin receptors to phosphorylate exogenous substrates was tested using the
synthetic peptide poly(Glu-Tyr (4:1)). Aliquots of the WGA eluate (100 µl containing 4 µg of protein) were incubated in the presence or
absence of insulin (16.7 milliunits/ml) for 60 min at 23 °C.
Poly(Glu-Tyr (4:1)) (28 µg in 20 µl) was then added, and the
reaction was initiated by the addition (20 µl) of a mixture containing 8 mM MgCl2, 600 µM
Na3VO4, 45 µM ATP, and 2 µCi of [ -32P]ATP (32). The reaction was allowed to proceed
for 30 min at 23 °C, and the reaction was terminated by spotting
aliquots of the reaction mixture on Whatman 31 ET filter paper. The
papers were washed extensively in 1% H3PO4,
rinsed in acetone, and then allowed to air dry prior to scintillation
counting.
Insulin Signaling in Skeletal Muscle--
Following an overnight
fast, rats were anesthetized, and a bolus of saline (0.5 cc) was
injected via a catheter placed in a jugular vein; after 120 s, the
soleus muscle from the right hind limb was excised and clamp frozen. A
bolus of insulin (10 units/kg body weight in 0.5 cc saline) was then
injected into the catheter, and after 120 s, the left soleus
muscle was excised and clamp frozen. Muscles were stored at 80 °C
until analysis of insulin-stimulated tyrosine phosphorylation.
Soleus muscle extracts were prepared by the method of Saad et
al. (33). For analysis of insulin receptor -subunit
autophosphorylation, aliquots of the solubilized muscle extract
containing 100 µg were subjected to SDS-polyacrylamide gel
electrophoresis (6.25% gel) and then transferred to polyvinylidene
difluoride membranes. The membranes were blocked overnight at 4 °C
in 1% BSA in 10 mM Tris, pH 7.5, 150 mM NaCl,
0.1% Tween 20 and then incubated with a polyclonal anti-phosphotyrosine antibody (1.5 µg/ml) followed by donkey
anti-rabbit 125IgG and exposure to x-ray film for 12-48 h.
For determination of IRS-1 tyrosine phosphorylation, an aliquot of the
muscle extract containing 1 mg of protein was incubated overnight at
4 °C with 4 µg of anti-rat IRS-1 antibody, followed by adsorption
with protein A-Sepharose for 60 min at 4 °C. The tyrosine
phosphorylation of immunoprecipitated IRS-1 was assessed by
immunoblotting with anti-phosphotyrosine antibody exactly as described
above for the insulin receptor -subunit.
IRS-1 protein content in the soluble muscle extracts (10 µg of
protein) was assessed by immunoblotting using an antibody directed against the 14 carboxyl-terminal amino acid residues of IRS-1, followed
by horseradish peroxidase-conjugated IgG. Antibody-bound protein was
visualized using enhanced chemiluminescence according to the
manufacturer's specifications. Protein bands were quantitated by
densitometry.
For analysis of muscle insulin receptor protein content, a crude total
membrane fraction was prepared (9). Membrane proteins (70 µg) were
resolved by SDS-polyacrylamide gel electrophoresis, transferred to
nitrocellulose, and then immunoblotted with a polyclonal antibody
directed against the carboxyl terminus of the -subunit of the
insulin receptor, followed by horseradish peroxidase-conjugated IgG.
Detection was performed using enhanced chemiluminescence. Protein bands
were quantitated using densitometry.
Statistical Analysis--
Data are presented as means ± S.E. Analysis of differences between the high fat-fed and chow-fed
control groups was performed using a Student's t test.
p < 0.05 was considered to be significant.
 |
RESULTS |
Effect of High Fat Diet on Weight Gain, Plasma Insulin, and
Glucose--
Rats that had been on the high fat diet for 8 weeks were
significantly heavier and had higher plasma insulin levels than
chow-fed controls of the same age (Table
I). After 30 weeks on the high fat diet,
the rats had become grossly obese and showed a further increase in
plasma insulin levels. In addition, most of the animals on the high fat
diet for 30 weeks had diabetic blood glucose levels (Table I).
Insulin- and Contraction-stimulated Glucose Transport
Activity--
The effect of 8 weeks of the high fat diet on glucose
transport activity in the isolated epitrochlearis muscle is shown in Fig. 1. 3-MG transport stimulated by a
maximally effective concentration of insulin was ~50% lower in
muscles from fat-fed animals. Glucose transport activity stimulated by
muscle contractions was similarly reduced (~50%) in muscles from
animals fed the high fat diet. These results are similar to those
reported previously by our group (6). We have also previously shown
that insulin-stimulated glucose transport is decreased in the soleus
and extensor digitorum longus muscles (6), so these measurements were
not repeated. In addition, it was previously found that the effect of
fat feeding is on insulin responsiveness, rather than insulin
sensitivity (6), and the effect of a submaximal insulin stimulus was
therefore not examined in this study.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 1.
Effect of 8 weeks of high fat feeding on 3-MG
transport in rat epitrochlearis muscles. Epitrochlearis muscles
were incubated for 60 min in the absence (basal) or presence (insulin)
of 2 milliunits/ml insulin or were stimulated to contract indirectly
via the nerve (contractions). Muscles were then washed for 10 min in
glucose-free medium, followed by measurement of glucose transport
activity using 3-MG as described under "Experimental Procedures."
Values are means ± S.E. for 5-10 muscles per group. Open
bars, chow-fed; solid bars, high fat diet-fed.
Significantly different from chow-fed, *p < 0.05.
|
|
Fat Feeding in GLUT1 Overexpressing Mice--
To investigate the
possibility that the high fat diet might be influencing glucose
transporter protein function by altering plasma membrane composition,
we studied the effect of high fat feeding on glucose transport in
skeletal muscle of mice overexpressing the GLUT1 glucose transporter.
Nontransgenic mice fed a high fat diet for 4 weeks were heavier than
chow-fed control mice (27.8 ± 1.3 g versus
23.4 ± 1.7 g for high fat and chow, respectively) and
exhibited a marked reduction in insulin-stimulated and
hypoxia-stimulated glucose transport activities in epitrochlearis and
EDL muscles (Fig. 2). Mice overexpressing
GLUT1 were also fed a high fat diet or standard rodent chow ad
libitum for 4 weeks. Like the wild-type mice, GLUT1 transgenic
mice fed the high fat diet were heavier than their chow-fed littermates
(27.4 ± 1.4 g versus 23.8 ± 0.5 g for
high fat-fed and chow, respectively). The high fat diet had no effect
on GLUT1 protein expression (2.04 ± 0.09 arbitrary units
versus 2.02 ± 0.05 arbitrary units in chow and high
fat-fed, respectively) or on basal glucose transport activity in the
isolated EDL or epitrochlearis muscles of the GLUT1 transgenic mice
(Fig. 3), suggesting that GLUT1-mediated
transport was not affected by the diet.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 2.
Effect of 4 weeks of high fat feeding on
stimulated glucose transport activity in epitrochlearis and EDL muscles
of wild-type mice. Muscles were incubated for 60 min at 35 °C
in oxygenated KHB containing 8 mM glucose, 32 mM mannitol, 0.1% BSA, and 2 milliunits/ml insulin
(Insulin) or in KHB gassed with 95% N2, 5%
CO2 containing 8 mM glucose, 32 mM
mannitol, and 0.1% BSA (Hypoxia). Muscles were then washed in
oxygenated, glucose-free buffer prior to measurement of glucose
transport activity using
2-deoxy-D-[3H]glucose (2-DG) as described
under "Experimental Procedures." When insulin was present during
the initial incubation, it was also present throughout the wash and
transport assay. Values are means ± S.E. for four
(epitrochlearis) or seven to nine (EDL) muscles per group. Open
bars, chow-fed; solid bars, high fat diet-fed.
Significantly different from chow-fed, *p < 0.05;
**p < 0.01.
|
|

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 3.
Effect of 4 weeks of high fat feeding on
basal glucose transport activity in epitrochlearis and EDL muscles of
GLUT1 overexpressing mice. Muscles were incubated for 60 min at
35 °C in KHB containing 8 mM glucose and 32 mM mannitol. Muscles were then transferred to glucose-free
KHB for 10 min at 30 °C prior to measurement of 3-MG transport as
described under "Experimental Procedures." Values are means ± S.E. for six to eight muscles per group. Open bars,
chow-fed; solid bars, high fat diet-fed.
|
|
Insulin-stimulated Amino Acid Transport Activity--
The system A
amino acid transporter is the primary insulin-regulatable neutral amino
acid transport system in skeletal muscle (34). In addition, insulin
stimulation of system A transport in skeletal muscle cells is
completely abolished by the phosphatidylinositol 3-kinase inhibitor
wortmannin (35), providing evidence that insulin stimulation of system
A amino acid transport and of glucose transport occurs via the same
proximal steps of the insulin signaling pathway. To obtain preliminary
information regarding the effect of the high fat diet on the insulin
signaling pathway and to further investigate the possibility that a
diet-induced alteration in plasma membrane composition might be
interfering with the function of membrane transporter proteins, we
examined the effect of 8 weeks of high fat feeding on system A amino
acid transport activity in the epitrochlearis muscle (Fig.
4). Basal MeAIB transport was unchanged
in muscles from high fat-fed animals compared with chow-fed controls.
In contrast to the defect in insulin-stimulated glucose transport
activity that occurs in muscles of the fat-fed animals, MeAIB transport
was stimulated to the same extent by insulin (~2-fold above basal) in
muscles from control and high fat-fed animals. This finding provides
further evidence that the high fat diet does not cause alterations in
plasma membrane composition that nonspecifically interfere with
function of membrane transporter proteins. In addition, these results
suggest that, after 8 weeks of high fat feeding, the early insulin
signaling events are intact in skeletal muscle and that the high fat
diet is acting on distal steps involved in stimulation of glucose
transport.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 4.
Effect of 8 weeks of high fat feeding on
insulin-stimulated system A amino acid transport activity in rat
epitrochlearis muscles. Muscles were incubated at 35 °C for 60 min in the presence or absence of 2 milliunits/ml insulin. They were
then washed for 10 min at 29 °C prior to measurement of system A
amino acid transport activity using 0.1 mM MeAIB as
described under "Experimental Procedures." If insulin was present
during the 35 °C incubation, it was also added to the wash and
transport media. Values are means ± S.E. for five to six muscles
per group. Open bars, basal; solid bars, 2 milliunits/ml insulin.
|
|
Insulin Receptor Tyrosine Kinase Activity--
To further evaluate
the effect of the high fat diet on insulin signaling, we measured the
tyrosine kinase activity of WGA-purified, solubilized skeletal muscle
insulin receptors toward an exogenous substrate. Insulin stimulated a
~4-fold increase in 32P incorporation into poly(Glu-Tyr
(4:1)) when receptors obtained from control animals were used.
Phosphorylation of the substrate was increased to a similar extent
(~4-fold above basal) in preparations from animals fed the high fat
diet for 8 weeks (Fig. 5A),
indicating that this duration of high fat feeding does not induce a
defect in the tyrosine kinase activity of the insulin receptor. In
contrast, assay of the receptors isolated from animals fed the high fat diet for 30 weeks shows that longer term high fat feeding resulted in a
decrease (~30%) in tyrosine kinase activity (Fig.
5B).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of high fat feeding on tyrosine kinase
activity of insulin receptors isolated from hind limb skeletal
muscle. Phosphorylation of poly(Glu-Tyr (4:1)) by WGA-purified
insulin receptors was measured in the absence (open
bars) or in the presence (solid bars) of 16.7 milliunits/ml insulin at 23 °C. Data are means ± S.E. for four
to eight samples per group. Significantly different from chow-fed,
*p < 0.01.
|
|
Insulin-stimulated Tyrosine Phosphorylation--
Impaired insulin
receptor function that was related to a change in the composition of
its membrane lipid environment would not necessarily be observed when
studying a solubilized receptor preparation. Therefore, to further
evaluate the effect of the high fat diet on insulin receptor function
in intact skeletal muscle, the phosphorylation of the insulin receptor
and its endogenous substrate IRS-1 were studied following in
situ administration of insulin (Fig.
6). There was no difference in
insulin-stimulated tyrosine phosphorylation of the -subunit of the
insulin receptor between the chow control and 8-week fat-fed groups. In
addition, 8 weeks of the high fat diet had no effect on tyrosine
phosphorylation of IRS-1. However, after 30 weeks on the high fat diet,
insulin-stimulated tyrosine phosphorylation of both the insulin
receptor and IRS-1 were reduced by ~30% (Fig. 6). The high fat
feeding had no significant effect on the content of muscle insulin
receptor (as assessed by -subunit content) or IRS-1 protein at
either 8 or 30 weeks.

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 6.
Effect of high fat feeding on
insulin-stimulated tyrosine phosphorylation of IR and IRS-1.
Animals were studied after 8 or 30 weeks on the high fat or chow
control diets. Animals were anesthetized, catheterized, and then given
an intravenous bolus of saline (basal) or insulin (10 units/kg body
wt). Soleus muscles were quickly excised and frozen 90-120 s after
administration of the saline or insulin. Frozen muscles were prepared
for quantitation of IR -subunit and IRS-1 tyrosine phosphorylation
by Western blotting as described under "Experimental Procedures."
Representative blots are shown at top of the figure. For
each experiment, the optical density of each chow-fed, basal sample was
set at 1.0. Values for all other samples from that blot were then
calculated relative to that sample. Values are means ± S.E. from
four to six rats. Open bars, basal; solid bars,
insulin. Significantly different from chow-fed, *p < 0.05.
|
|
Insulin- and Contraction-stimulated Cell Surface GLUT4
Labeling--
Although the early signaling events through which
insulin and contractions increase muscle glucose transport activity are independent, both stimuli increase glucose transport by increasing the
number of GLUT4 transporters at the cell surface (15, 17, 18). Since
the insulin- and the contraction-stimulated activations of muscle
glucose transport are similarly impaired in the fat-fed animals, it
seemed possible that the diet-induced defect might involve a step in
the translocation process. To test the effect of fat feeding on GLUT4
translocation, we used the bis-mannose derivative
ATB-[2-3H]BMPA to label transporters at the cell surface
in the epitrochlearis muscle following treatment with insulin or muscle
contractions. The increase in GLUT4 labeling following incubation with
a maximally effective concentration of insulin was 26% lower in
muscles of fat-fed animals compared with controls (Fig.
7). Similarly, high fat feeding resulted
in a 36% smaller increase in cell surface GLUT4 labeling following
in situ muscle contractions. Thus, it seems that a smaller
increase in cell surface GLUT4 plays a major role in the impaired
stimulation of glucose transport in the fat-fed animals. The disparity
between the magnitudes of the defects in transport and GLUT4
translocation, however, suggests that another mechanism also
contributes to the resistance of glucose transport to stimulation in
muscles of fat-fed animals.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 7.
Effect of 8 weeks of fat feeding on insulin-
and contraction-stimulated GLUT4 cell surface labeling in rat
epitrochlearis muscles. Muscles were incubated for 60 min in the
absence or presence of 2 milliunits/ml insulin or were stimulated to
contract, as described in the legend to Fig. 1. Muscles were washed for
10 min in glucose-free KHB and then further incubated in the dark at
18 °C for 8 min in buffer containing 0.75 mCi/ml
ATB-[3H]BMPA and insulin, if it was present in the
previous incubations. Muscles were then irradiated for 2 × 1 min.
Muscle membranes were prepared, and labeled GLUT4 glucose transporters
were immunoprecipitated and analyzed as described previously. Values
are means ± S.E. for six to nine muscles/group. Open
bars, chow-fed; closed bars, fat-fed. Significantly
different from chow-fed, *p < 0.05, **p < 0.01.
|
|
 |
DISCUSSION |
Feeding rodents a high fat diet results in visceral obesity,
muscle insulin resistance, and, if continued sufficiently long enough,
impaired glucose tolerance or diabetes (1-6). One mechanism that has
been suggested to explain the insulin resistance of muscle glucose
transport that develops with fat feeding and obesity is a change in the
lipid composition of the plasma membrane (4, 22). This seemed a
reasonable possibility, as membrane lipid composition can affect the
functioning of membrane-associated proteins (reviewed in Ref. 36), and
two of the key proteins involved in the regulation of glucose
transport, the glucose transporter and the insulin receptor, are
constituents of the plasma membrane. There is considerable evidence
that the catalytic activities of the glucose transporters (20, 21) and
the binding properties of the insulin receptor (37-39) are markedly
sensitive to changes in the properties of the membrane lipid
bilayer.
Two isoforms of the glucose transporter, GLUT4 (24, 25, 40-42) and
GLUT1 (43, 44), are expressed in skeletal muscle. The GLUT4 isoform
mediates the increase in glucose transport in response to insulin or
muscle contractions by a process that involves the movement of GLUT4 to
plasma membrane domains (15, 17, 18). The less abundant isoform, GLUT1,
seems to reside constitutively in the plasma membrane (45, 46) and is
thought to mediate basal glucose transport (26, 27). These two
transporters are structurally similar (24, 25) and are thought to
transport glucose across the plasma membrane by the same process. In
this context, we used the muscles of transgenic mice that overexpress GLUT1 to evaluate the possibility that a high fat diet causes a change
in membrane composition that impairs glucose transporter function. Our
results show that a high fat diet that results in severe muscle insulin
resistance in wild-type mice has no effect on the high rate of glucose
transport in the muscles of GLUT1 overexpressing mice. This finding
suggests that an impairment of glucose transporter function mediated by
a change in membrane composition is not responsible for the decrease in
muscle glucose transport activity caused by a high fat diet. We cannot
rule out the possibility that GLUT1 and GLUT4 might respond differently to changes in the composition of the plasma membrane lipid bilayer, but
the similarities in the structure of the two transporter isoforms, especially in the putative membrane-spanning regions (24, 25), make
this unlikely. Further evidence against a diet-induced change in the
composition or physical properties of the plasma membrane that causes a
nonspecific decrease in membrane-associated protein activity is
provided by our finding that skeletal muscle system A amino acid
transport activity is not impaired after 8 weeks on the high fat
diet.
It has been hypothesized on the basis of studies on human skeletal
muscle that a defect at the level of the insulin receptor contributes
to the insulin resistance associated with obesity (7-9). There is much
evidence that it is abdominal, particularly visceral, obesity that is
associated with insulin resistance (the so called abdominal or central
obesity syndrome) (47, 48). Rodents fed a high fat diet rapidly develop
an increase in visceral fat. In rats fed the high fat diet used in the
present study, total visceral fat weight (retroperitoneal, mesenteric,
and epididymal fat depots) is already ~50% greater than in chow-fed
controls after 8 weeks (6). In this context, it seemed possible that the insulin resistance induced by a high fat diet could be mediated either by a membrane composition-related change in receptor function (38, 39, 49) or as a consequence of decreased receptor number and/or
activity associated with the obesity (7-9, 50). The initial steps in
the stimulation of system A amino acid transport by insulin are the
same as those involved in the stimulation of glucose transport (35).
Our finding that stimulation of MeAIB transport by insulin is not
decreased in muscles of rats fed the high fat diet for 8 weeks,
therefore, argues against an impairment of insulin receptor function
early in the development of the insulin resistance induced by a high
fat diet.
The interpretation that muscle insulin receptor function is normal in
rats after 8 weeks on the high fat diet is supported by our finding
that stimulated tyrosine kinase activity of solubilized receptors from
8-week fat-fed and chow-fed control rats is similar. Our results are
consistent with previous studies in muscle in which relatively short
periods of high fat feeding (4-5 weeks) were shown to have little or
no effect on insulin binding (51, 52) and insulin-stimulated
autophosphorylation (52) or tyrosine kinase activity (51) of partially
purified receptors. In addition, the lack of effect of 8 weeks of fat
feeding on insulin-stimulated tyrosine phosphorylation of the receptor
-subunit and IRS-1 is in agreement with the findings of Okamoto
et al. (52), in which phosphorylation of the insulin
receptor and pp190 in rat skeletal muscle following in vivo
insulin administration was not changed by 4 weeks of high fat feeding.
However, rats fed the high fat diet for 30 weeks in our studies did
have decreases in insulin receptor tyrosine kinase activity and in
insulin-stimulated insulin receptor and IRS-1 tyrosine phosphorylation;
by this time, plasma insulin levels in the high fat-fed animals had
been elevated for ~4 months. Thus, our results are consistent with
the finding of an insulin receptor defect in muscles of
insulin-resistant patients with obesity and glucose intolerance or
diabetes (7-9), as such individuals have generally been
hyperinsulinemic for years. We interpret these findings to indicate
that a defect in insulin signaling is a late event that is probably
secondary to prolonged hyperinsulinemia and is not a primary cause of
the insulin resistance.
In keeping with the interpretation that the insulin resistance of
muscle glucose transport induced by 4-8 weeks on a high fat diet is
not due to impairment of insulin signaling is the finding that
stimulation of glucose transport by contractile activity, or hypoxia,
is also reduced. Contractions and hypoxia stimulate glucose transport
by a pathway that is separate from, and independent of, the insulin
signaling pathway (13-15). Since both insulin-stimulated and
contraction-stimulated glucose transport are impaired by fat feeding,
it seems likely that it is a late, common step that is affected. Our
finding that the increases in GLUT4 at the cell surface in response to
both insulin and contractions were smaller in muscles of fat-fed rats
as compared with controls provides evidence that a step(s) involved in
translocation of GLUT4-containing vesicles to, or fusion with, the
sarcolemma is impaired. Reduced insulin-stimulated GLUT4 translocation
in soleus muscles of mice fed a high fat diet has also been reported by
Zierath et al. (19). This smaller increase in GLUT4 at the
cell surface is not due to a decrease in total muscle GLUT4, as muscle
GLUT4 protein content is unaffected in rats fed a high fat diet such as
was used in this study (6, 16).
Our finding that the impairment of stimulated transport was greater
than the decrease in GLUT4 movement to the cell surface raises the
possibility that GLUT4 intrinsic activity may also be reduced in the
fat-fed animals. Evidence that a high fat diet may alter GLUT4
intrinsic activity has been provided by Rosholt et al. (16),
who found that the GLUT4 in plasma membrane vesicles prepared from
muscles of high fat diet-fed rats had a lower transport capacity than
GLUT4 in vesicles prepared from chow-fed controls. There is currently
no information regarding how high fat feeding might bring about a
change in intrinsic activity. One possibility is that the GLUT4 protein
is modified prior to translocation. Another possibility is that the
composition of the GLUT4 vesicle-derived lipid annulus of the
transporter protein is changed. The third possibility, that reduced
intrinsic activity of GLUT4 could be mediated by changes in the
membrane lipid composition that result in impaired function of the
transporter after its insertion into the plasma membrane, now seems
unlikely in light of our finding that activity of the GLUT1
transporter, which is constitutively targeted to the plasma membrane,
is unaffected.
In conclusion, our findings on muscles of transgenic mice
overexpressing the GLUT1 glucose transporter provide evidence that the
impairment of muscle glucose transport induced by a high fat diet is
not due to a change in sarcolemmal composition that interferes with
glucose transporter function. Our results further show that insulin
receptor down-regulation does not play a primary role in causing the
muscle insulin resistance induced by feeding a high fat diet. Both the
contraction-stimulated and insulin-stimulated increases in GLUT4 at the
cell surface are reduced in muscles of fat-fed rats, suggesting an
impairment of one or more of the steps involved in the GLUT4
translocation process.
 |
ACKNOWLEDGEMENTS |
We thank Tim Meyer, Vanessa Kieu, and Nancy
Ensor for excellent technical assistance.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grants DK18986 (to J. O. H.), DK02339 (to B. A. M.), and DK38495 (to M. M.) and Diabetes Research and Training Center Grant DK20579.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Dept. of Medicine,
Washington University School of Medicine, 4566 Scott Ave., Campus Box
8113, St. Louis, MO 63110. Tel.: 314-747-1485; Fax: 314-362-7657;
E-mail: phansen{at}imgate.wustl.edu.
¶
Supported by a mentor-based fellowship from the American
Diabetes Association.
**
Supported by grants from the John Henry and Bernadine Foster
Foundation, the Hardison Family Foundation, and a Scholar of the Child
Health Research Center of Excellence in Developmental Biology at
Washington University School of Medicine (HD33688).

Initially supported by a mentor-based fellowship from the
American Diabetes Association and subsequently by National Institute on
Aging Postdoctoral Training Grant AG00078.
The abbreviations used are:
ATB-[2-3H]BMPA, 2-N-4-(1-azi2,2,2-trifluoroethyl)-benzoyl-1,3-bis-(D-mannose-4-yloxy)-2-propylamineEDL, extensor digitorum longusBSA, bovine serum albumin3-MG, 3-O-methyl-D-glucoseMeAIB, -(methylamino)isobutyrateWGA, wheat germ agglutininIR, insulin
receptorIRS-1, insulin receptor substrate-1.
 |
REFERENCES |
-
Kraegen, E. W.,
James, D. E.,
Storlien, L. H.,
Burleigh, K. M.,
and Chisholm, D. J.
(1986)
Diabetologia
29,
192-198[CrossRef][Medline]
[Order article via Infotrieve]
-
Storlien, L. H.,
James, D. E.,
Burleigh, K. M.,
Chisholm, D. J.,
and Kraegen, E. W.
(1986)
Am. J. Physiol.
251,
E576-E583[Abstract/Free Full Text]
-
Surwit, R. S.,
Kuhn, C. M.,
Cochrane, C.,
McCubbin, J. A.,
and Feinglos, M. N.
(1988)
Diabetes
37,
1163-1167[Abstract]
-
Storlien, L. H.,
Jenkins, A. B.,
Chisholm, D. J.,
Pascoe, W. S.,
Khouri, S.,
and Kraegen, E. W.
(1991)
Diabetes
40,
280-289[Abstract]
-
Pagliassotti, M. J.,
Knobel, S. M.,
Shahrokhi, K. A.,
Manzo, A. M.,
and Hill, J. O.
(1994)
Am. J. Physiol.
267,
R659-R664[Abstract/Free Full Text]
-
Han, D. H.,
Hansen, P. A.,
Host, H. H.,
and Holloszy, J. O.
(1997)
Diabetes
46,
1761-1767[Abstract]
-
Caro, J. F.,
Sinha, M. K.,
Raju, S. M.,
Ittoop, O.,
Pories, W. J.,
Flickinger, E. G.,
Meelheim, D.,
and Dohm, G. L.
(1987)
J. Clin. Invest.
79,
1330-1337
-
Arner, P.,
Pollare, T.,
Lithell, H.,
and Livingston, J. N.
(1987)
Diabetologia
30,
437-440[CrossRef][Medline]
[Order article via Infotrieve]
-
Goodyear, L. J.,
Giorgino, F.,
Sherman, L. A.,
Carey, J.,
Smith, R. J.,
and Dohm, G. L.
(1995)
J. Clin. Invest.
95,
2195-2204
-
Holloszy, J. O.,
and Hansen, P. A.
(1996)
in
Reviews of Physiology, Biochemistry and Pharmacology (Blaustein, M. P., Grunicke, H., Habermann, E., Pette, D., Schultz, G., and Schweiger, M., eds), pp. 99-193, Springer-Verlag, New York
-
Nesher, R.,
Karl, I. E.,
and Kipnis, D. M.
(1985)
Am. J. Physiol.
249,
C226-C232[Abstract/Free Full Text]
-
Zorzano, A.,
Balon, T. W.,
Goodman, M. N.,
and Ruderman, N. B.
(1986)
Am. J. Physiol.
251,
E21-E26[Abstract/Free Full Text]
-
Yeh, J.-I.,
Gulve, E. A.,
Rameh, L.,
and Birnbaum, M. J.
(1995)
J. Biol. Chem.
270,
2107-2111[Abstract/Free Full Text]
-
Lee, A. D.,
Hansen, P. A.,
and Holloszy, J. O.
(1995)
FEBS Lett.
361,
51-54[CrossRef][Medline]
[Order article via Infotrieve]
-
Lund, S.,
Holman, G. D.,
Schmitz, O.,
and Pedersen, O.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
5817-5821[Abstract/Free Full Text]
-
Rosholt, M. N.,
King, P. A.,
and Horton, E. S.
(1994)
Am. J. Physiol.
266,
R95-R101[Abstract/Free Full Text]
-
Lund, S.,
Holman, G. D.,
Schmitz, O.,
and Pedersen, O.
(1993)
FEBS Lett.
330,
312-318[CrossRef][Medline]
[Order article via Infotrieve]
-
Wilson, C. M.,
and Cushman, S. W.
(1994)
Biochem. J.
299,
755-759
-
Zierath, J. R.,
Houseknecht, K. L.,
Gnudi, L.,
and Kahn, B. B.
(1997)
Diabetes
46,
215-223[Abstract]
-
Carruthers, A.,
and Melchior, D. L.
(1984)
Biochemistry
23,
6901-6911[CrossRef][Medline]
[Order article via Infotrieve]
-
Sandra, A.,
Fyler, D. J.,
and Marshall, S. J.
(1984)
Biochim. Biophys. Acta
778,
511-515[Medline]
[Order article via Infotrieve]
-
Borkman, M.,
Storlien, L. H.,
Pan, D. A.,
Jenkins, A. B.,
Chisholm, D. J.,
and Campbell, L. V.
(1993)
N. Engl. J. Med.
328,
238-244[Abstract/Free Full Text]
-
Stevenson, R. W.,
McPherson, R. K.,
Persson, L. M.,
Genereux, P. E.,
Swick, A. G.,
Spitzer, J.,
Herbst, J. J.,
Andrews, K. M.,
Kreutter, D. K.,
and Gibbs, E. M.
(1996)
Diabetes
45,
60-66[Abstract]
-
James, D. E.,
Strube, M.,
and Mueckler, M.
(1989)
Nature
338,
83-87[CrossRef][Medline]
[Order article via Infotrieve]
-
Birnbaum, M. J.
(1989)
Cell
57,
305-315[CrossRef][Medline]
[Order article via Infotrieve]
-
Marshall, B. A.,
Ren, J.-M.,
Johnson, D. W.,
Gibbs, E. M.,
Lillquist, J. S.,
Soeller, W. C.,
Holloszy, J. O.,
and Mueckler, M.
(1993)
J. Biol. Chem.
268,
18442-18445[Abstract/Free Full Text]
-
Ren, J.-M.,
Marshall, B. A.,
Gulve, E. A.,
Gao, J.,
Johnson, D. W.,
Holloszy, J. O.,
and Mueckler, M.
(1993)
J. Biol. Chem.
268,
16113-13115[Abstract/Free Full Text]
-
Young, D. A.,
Uhl, J. J.,
Cartee, G. D.,
and Holloszy, J. O.
(1986)
J. Biol. Chem.
261,
16049-16053[Abstract/Free Full Text]
-
Gulve, E. A.,
Cartee, G. D.,
Youn, J. H.,
and Holloszy, J. O.
(1991)
Am. J. Physiol.
260,
C88-C95[Abstract/Free Full Text]
-
Hansen, P. A.,
Corbett, J. A.,
and Holloszy, J. O.
(1997)
Am. J. Physiol.
273,
E28-E36[Abstract/Free Full Text]
-
Burant, C. F.,
Treutelaar, M. K.,
Landreth, G. E.,
and Buse, M. G.
(1984)
Diabetes
33,
704-708[Abstract]
-
Bak, J. F.,
Handberg, A.,
Beck-Nielsen, H.,
and Pedersen, O.
(1990)
Biochim. Biophys. Acta
1052,
306-312[Medline]
[Order article via Infotrieve]
-
Saad, M. J. A.,
Araki, E.,
Miralpeix, M.,
Rothenberg, P. L.,
White, M. F.,
and Kahn, C. R.
(1992)
J. Clin. Invest.
90,
1839-1849
-
Riggs, T. R.,
and McKirahan, K. J.
(1973)
J. Biol. Chem.
248,
6450-6455[Abstract/Free Full Text]
-
Tsakiridis, T.,
McDowell, H. E.,
Walker, T.,
Downes, C. P.,
Hundal, H. S.,
Vranic, M.,
and Klip, A.
(1995)
Endocrinology
136,
4315-4322[Abstract]
-
Clandinin, M. T.,
Cheema, S.,
Field, C. J.,
Garg, M. L.,
Venkatraman, J.,
and Clandinin, T. R.
(1991)
FASEB J.
5,
2761-2769[Abstract]
-
Gould, R. J.,
Ginsberg, B. H.,
and Spector, A. A.
(1982)
J. Biol. Chem.
257,
477-484[Abstract/Free Full Text]
-
van Amelsvoort, J. M. M.,
van der Beek, A.,
and Stam, J. J.
(1986)
Ann. Nutr. Metab.
30,
273-280[Medline]
[Order article via Infotrieve]
-
Field, C. J.,
Ryan, E. A.,
Thomson, A. B. R.,
and Clandinin, M. T.
(1990)
J. Biol. Chem.
265,
11143-11150[Abstract/Free Full Text]
-
Charron, M. J.,
Brosius, F. D.,
Alper, S. L.,
and Lodish, H. F.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
2535-2539[Abstract/Free Full Text]
-
Fukumoto, H.,
Kayano, T.,
Buse, J. B.,
Edwards, Y.,
Pilch, P. F.,
Bell, G. I.,
and Seino, S.
(1989)
J. Biol. Chem.
264,
7776-7779[Abstract/Free Full Text]
-
Kaestner, K. H.,
Christy, R. J.,
McLenithan, J. C.,
Braiterman, L. T.,
Corneliuis, P.,
Pekala, P. H.,
and Lane, M. D.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
3150-3154[Abstract/Free Full Text]
-
Birnbaum, M. J.,
Haspel, H. C.,
and Rosen, O. M.
(1986)
Proc. Natl. Acad. Sci. U. S. A.
83,
5784-5788[Abstract/Free Full Text]
-
Mueckler, M.,
Caruso, C.,
Baldwin, S. A.,
Panico, M.,
Blench, I.,
Morris, H. R.,
Allard, W. J.,
Lienhard, G. E.,
and Lodish, H. F.
(1985)
Science
229,
941-945[Abstract/Free Full Text]
-
Marette, E.,
Richardson, J. M.,
Ramlal, T.,
Balon, T. W.,
Vranic, M.,
Pessin, J. E.,
and Klip, A.
(1992)
Am. J. Physiol.
263,
C443-C452[Abstract/Free Full Text]
-
Wang, W.,
Hansen, P. A.,
Marshall, B. A.,
Holloszy, J. O.,
and Mueckler, M.
(1996)
J. Cell Biol.
135,
415-430[Abstract/Free Full Text]
-
Després, J.-P.,
Nadeau, A.,
Tremblay, A.,
Ferland, M.,
Moorjani, S.,
Lupien, P. J.,
Theriault, G.,
Pinault, S.,
and Bouchard, C.
(1989)
Diabetes
38,
304-309[Abstract]
-
Kissebah, A. H.
(1991)
Int. J. Obes.
15,
109-115
-
Liu, S.,
Baracos, V. E.,
Quinney, H. A.,
and Clandinin, M. T.
(1994)
Biochem. J.
299,
831-837
-
Le Marchand-Brustel, Y.,
Grémeaux, T.,
Ballotti, R.,
and Van Obberghen, E.
(1985)
Nature
315,
676-679[CrossRef][Medline]
[Order article via Infotrieve]
-
Boyd, J. J.,
Contreras, I.,
Kern, M.,
Tapscott, E. B.,
Downes, D. L.,
Frisell, W. R.,
and Dohm, G. L.
(1990)
Am. J. Physiol.
259,
E111-E116[Abstract/Free Full Text]
-
Okamoto, M.,
Okamoto, M.,
Kono, S.,
Inoue, G.,
Hayashi, T.,
Kosaki, A.,
Maeda, I.,
Kubota, M.,
Kuzuya, H.,
and Imura, H.
(1992)
J. Nutr. Biochem.
3,
241-250
[CrossRef]
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. Galuska, O. Kotova, R. Barres, D. Chibalina, B. Benziane, and A. V. Chibalin
Altered expression and insulin-induced trafficking of Na+-K+-ATPase in rat skeletal muscle: effects of high-fat diet and exercise
Am J Physiol Endocrinol Metab,
July 1, 2009;
297(1):
E38 - E49.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D.-H. Han, C. Hancock, S.-R. Jung, and J. O. Holloszy
Is "fat-induced" muscle insulin resistance rapidly reversible?
Am J Physiol Endocrinol Metab,
July 1, 2009;
297(1):
E236 - E241.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. B. Yaspelkis III, I. A. Kvasha, and T. Y. Figueroa
High-fat feeding increases insulin receptor and IRS-1 coimmunoprecipitation with SOCS-3, IKK{alpha}/{beta} phosphorylation and decreases PI-3 kinase activity in muscle
Am J Physiol Regulatory Integrative Comp Physiol,
June 1, 2009;
296(6):
R1709 - R1715.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Schertzer, C. N. Antonescu, P. J. Bilan, S. Jain, X. Huang, Z. Liu, A. Bonen, and A. Klip
A Transgenic Mouse Model to Study Glucose Transporter 4myc Regulation in Skeletal Muscle
Endocrinology,
April 1, 2009;
150(4):
1935 - 1940.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. O Holloszy
Skeletal muscle "mitochondrial deficiency" does not mediate insulin resistance
Am. J. Clinical Nutrition,
January 1, 2009;
89(1):
463S - 466S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Bourgoin, H. Bachelard, M. Badeau, S. Melancon, M. Pitre, R. Lariviere, and A. Nadeau
Endothelial and vascular dysfunctions and insulin resistance in rats fed a high-fat, high-sucrose diet
Am J Physiol Heart Circ Physiol,
September 1, 2008;
295(3):
H1044 - H1055.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. R. Hancock, D.-H. Han, M. Chen, S. Terada, T. Yasuda, D. C. Wright, and J. O. Holloszy
High-fat diets cause insulin resistance despite an increase in muscle mitochondria
PNAS,
June 3, 2008;
105(22):
7815 - 7820.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Henriksen, M. K. Teachey, K. A. Lindborg, C. J. Diehl, and A. N. Beneze
The high-fat-fed lean Zucker rat: a spontaneous isocaloric model of fat-induced insulin resistance associated with muscle GSK-3 overactivity
Am J Physiol Regulatory Integrative Comp Physiol,
June 1, 2008;
294(6):
R1813 - R1821.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R Vinayagamoorthi, Z. Bobby, and M G Sridhar
Antioxidants preserve redox balance and inhibit c-Jun-N-terminal kinase pathway while improving insulin signaling in fat-fed rats: evidence for the role of oxidative stress on IRS-1 serine phosphorylation and insulin resistance
J. Endocrinol.,
May 1, 2008;
197(2):
287 - 296.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. P.M. M. Lauritzen, T. Ploug, H. Ai, M. Donsmark, C. Prats, and H. Galbo
Denervation and High-Fat Diet Reduce Insulin Signaling in T-Tubules in Skeletal Muscle of Living Mice
Diabetes,
January 1, 2008;
57(1):
13 - 23.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. B. Yaspelkis III, S. J. Lessard, D. W. Reeder, J. J. Limon, M. Saito, D. A. Rivas, I. Kvasha, and J. A. Hawley
Exercise reverses high-fat diet-induced impairments on compartmentalization and activation of components of the insulin-signaling cascade in skeletal muscle
Am J Physiol Endocrinol Metab,
October 1, 2007;
293(4):
E941 - E949.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Frangioudakis, J.-M. Ye, and G. J. Cooney
Both Saturated and n-6 Polyunsaturated Fat Diets Reduce Phosphorylation of Insulin Receptor Substrate-1 and Protein Kinase B in Muscle during the Initial Stages of in Vivo Insulin Stimulation
Endocrinology,
December 1, 2005;
146(12):
5596 - 5603.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. J. Herr, J. R. Bernard, D. W. Reeder, D. A. Rivas, J. J. Limon, and B. B. Yaspelkis III
Insulin-stimulated plasma membrane association and activation of Akt2, aPKC {zeta} and aPKC {lambda} in high fat fed rodent skeletal muscle
J. Physiol.,
June 1, 2005;
565(2):
627 - 636.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Sancho, J. Kim, and G. D. Cartee
Decreased contraction-stimulated glucose transport in isolated epitrochlearis muscles of pregnant rats
J Appl Physiol,
March 1, 2005;
98(3):
1021 - 1027.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. L. Pehleman, S. J. Peters, G. J. F. Heigenhauser, and L. L. Spriet
Enzymatic regulation of glucose disposal in human skeletal muscle after a high-fat, low-carbohydrate diet
J Appl Physiol,
January 1, 2005;
98(1):
100 - 107.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. C. Wright, P. C. Geiger, M. J. Rheinheimer, D. H. Han, and J. O. Holloszy
Phorbol esters affect skeletal muscle glucose transport in a fiber type-specific manner
Am J Physiol Endocrinol Metab,
August 1, 2004;
287(2):
E305 - E309.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. D. Krisan, D. E. Collins, A. M. Crain, C. C. Kwong, M. K. Singh, J. R. Bernard, and B. B. Yaspelkis III
Resistance training enhances components of the insulin signaling cascade in normal and high-fat-fed rodent skeletal muscle
J Appl Physiol,
May 1, 2004;
96(5):
1691 - 1700.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. T. Fueger, D. P. Bracy, C. M. Malabanan, R. R. Pencek, D. K. Granner, and D. H. Wasserman
Hexokinase II Overexpression Improves Exercise-Stimulated But Not Insulin-Stimulated Muscle Glucose Uptake in High-Fat-Fed C57BL/6J Mice
Diabetes,
February 1, 2004;
53(2):
306 - 314.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D.-H. Han, M. M. Chen, and J. O. Holloszy
Glucosamine and glucose induce insulin resistance by different mechanisms in rat skeletal muscle
Am J Physiol Endocrinol Metab,
December 1, 2003;
285(6):
E1267 - E1272.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Nolte, D.-H. Han, P. A. Hansen, K. A. Hucker, and J. O. Holloszy
A Peroxovanadium Compound Stimulates Muscle Glucose Transport as Powerfully as Insulin and Contractions Combined
Diabetes,
August 1, 2003;
52(8):
1918 - 1925.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Folmer, J. C. M. Soares, D. Gabriel, and J. B. T. Rocha
A High Fat Diet Inhibits {delta}-Aminolevulinate Dehydratase and Increases Lipid Peroxidation in Mice (Mus musculus)
J. Nutr.,
July 1, 2003;
133(7):
2165 - 2170.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Niu, C. Huang, Z. Nawaz, M. Levy, R. Somwar, D. Li, P. J. Bilan, and A. Klip
Maturation of the Regulation of GLUT4 Activity by p38 MAPK during L6 Cell Myogenesis
J. Biol. Chem.,
May 9, 2003;
278(20):
17953 - 17962.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. He, M. Thamotharan, and S. U. Devaskar
Insulin-induced translocation of facilitative glucose transporters in fetal/neonatal rat skeletal muscle
Am J Physiol Regulatory Integrative Comp Physiol,
April 1, 2003;
284(4):
R1138 - R1146.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. O. Holloszy
A forty-year memoir of research on the regulation of glucose transport into muscle
Am J Physiol Endocrinol Metab,
March 1, 2003;
284(3):
E453 - E467.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Tremblay, C. Lavigne, H. Jacques, and A. Marette
Dietary Cod Protein Restores Insulin-Induced Activation of Phosphatidylinositol 3-Kinase/Akt and GLUT4 Translocation to the T-Tubules in Skeletal Muscle of High-Fat-Fed Obese Rats
Diabetes,
January 1, 2003;
52(1):
29 - 37.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Sreekumar, J. Unnikrishnan, A. Fu, J. Nygren, K. R. Short, J. Schimke, R. Barazzoni, and K. S. Nair
Impact of high-fat diet and antioxidant supplement on mitochondrial functions and gene transcripts in rat muscle
Am J Physiol Endocrinol Metab,
May 1, 2002;
282(5):
E1055 - E1061.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. Youngren, J. Paik, and R. J. Barnard
Impaired insulin-receptor autophosphorylation is an early defect in fat-fed, insulin-resistant rats
J Appl Physiol,
November 1, 2001;
91(5):
2240 - 2247.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Tremblay, C. Lavigne, H. Jacques, and A. Marette
Defective Insulin-Induced GLUT4 Translocation in Skeletal Muscle of High Fat-Fed Rats Is Associated With Alterations in Both Akt/Protein Kinase B and Atypical Protein Kinase C ({zeta}/{lambda}) Activities
Diabetes,
August 1, 2001;
50(8):
1901 - 1910.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Nolte, K. E. Yarasheski, K. Kawanaka, J. Fisher, N. Le, and J. O. Holloszy
The HIV Protease Inhibitor Indinavir Decreases Insulin- and Contraction-Stimulated Glucose Transport in Skeletal Muscle
Diabetes,
June 1, 2001;
50(6):
1397 - 1401.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
B. B. Yaspelkis III, J. R. Davis, M. Saberi, T. L. Smith, R. Jazayeri, M. Singh, V. Fernandez, B. Trevino, N. Chinookoswong, J. Wang, et al.
Leptin administration improves skeletal muscle insulin responsiveness in diet-induced insulin-resistant rats
Am J Physiol Endocrinol Metab,
January 1, 2001;
280(1):
E130 - E142.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-Y. Kim, L. A. Nolte, P. A. Hansen, D.-H. Han, K. Ferguson, P. A. Thompson, and J. O. Holloszy
High-fat diet-induced muscle insulin resistance: relationship to visceral fat mass
Am J Physiol Regulatory Integrative Comp Physiol,
December 1, 2000;
279(6):
R2057 - R2065.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W. Anderson, E. C. Konz, and D. J. A. Jenkins
Health Advantages and Disadvantages of Weight-Reducing Diets: A Computer Analysis and Critical Review
J. Am. Coll. Nutr.,
October 1, 2000;
19(5):
578 - 590.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-H. Kim, J. H. Youn, J.-Y. Park, S. K. Hong, K. S. Park, S. W. Park, K. I. Suh, and K.-U. Lee
Effects of high-fat diet and exercise training on intracellular glucose metabolism in rats
Am J Physiol Endocrinol Metab,
June 1, 2000;
278(6):
E977 - E984.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Marshall, P. A. Hansen, N. J. Ensor, M. A. Ogden, and M. Mueckler
GLUT-1 or GLUT-4 transgenes in obese mice improve glucose tolerance but do not prevent insulin resistance
Am J Physiol Endocrinol Metab,
February 1, 1999;
276(2):
E390 - E400.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Nugent, J. B. Prins, J. P. Whitehead, J. M. Wentworth, V. K. K. Chatterjee, and S. O'Rahilly
Arachidonic Acid Stimulates Glucose Uptake in 3T3-L1 Adipocytes by Increasing GLUT1 and GLUT4 Levels at the Plasma Membrane. EVIDENCE FOR INVOLVEMENT OF LIPOXYGENASE METABOLITES AND PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR gamma
J. Biol. Chem.,
March 16, 2001;
276(12):
9149 - 9157.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|